Concepedia

Publication | Open Access

Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1

DOIFull Paper Access

110

Citations

38

References

2013

Year

Phoebe Rich, Marc Bourcier, Howard Sofen, Steven Fakharzadeh, Yasmine Wasfi, Y. Wang, Urs Kerkmann, Pierre‐Dominique Ghislain, Yves Poulin
British Journal of Dermatology

Abstract

Ustekinumab significantly improves nail psoriasis, and improvements continue over time until up to 1 year of treatment in those receiving maintenance treatment.

References

YearCitations

Page 1